Immunotherapy for lung cancer Doctors Abroad — Page 2

Professor Ercan Ozden is a medical oncology specialist at VM Medical Park Pendik who focus on targeted cancer therapies. He completed his internal medicine training at Istanbul University Cerrahpasa Faculty of Medicine.

• Specialises in medical oncology and subspecialty internal medicine
• Expertise in managing systemic treatments for thoracic malignancies
• Graduated from the prestigious English Medical Programme at Istanbul University
• Practises at VM Medical Park – a major Turkish hospital group known for oncology

Associate Professor Muhammed Mustafa Atci is a lead medical oncologist at Istinye University Liv Hospital Topkapi and an Education Coordinator for oncology specialists.

• Specialises in non-small cell lung cancer and metastatic cases
• Published research on how body mass index and age impact lung cancer treatment outcomes
• Member of the American Society of Clinical Oncology (ASCO)
• Focuses on tailoring therapy based on clinical and pathological characteristics

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Associate Professor Hasan Mutlu is a specialist medical oncologist at Medical Park Antalya who focuses on targeted cancer therapies and next-generation genetic research.

• Specialises in precise immunotherapy protocols for non-small cell and small cell lung cancers
• Experienced in next-generation genetic research to identify specific tumour markers
• Trained at Akdeniz University – a major Turkish centre for internal medicine research
• Expert in combining targeted chemotherapy with modern immunotherapy agents
• Focuses on organ-specific tumours and complementary medicine approaches

Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

• Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
• Authored over 40 research articles in journals indexed by SCI and SSCI.
• Completed dual fellowships in allergy-immunology and medical oncology.
• Treats complex sarcomas and renal cell carcinomas with systemic therapies.

Associate Professor Atakan Topcu is a leading medical oncologist who combines targeted immunotherapy with a specialised focus on lung cancer patient recovery and well-being.

• Serves on the editorial board of BMC Cancer, a prestigious international peer-reviewed medical journal
• Specialises in managing immunotherapy side effects and cancer-related malnutrition in lung cancer cases
• Completed a clinical observership at the University of Leicester in the United Kingdom
• Published over 50 scientific articles focusing on solid tumours and immunotherapy outcomes
• Member of the European Society for Medical Oncology (ESMO)

Associate Professor Ayse Irem Yasin is an ESMO-certified oncologist who manages complex lung cancer cases at Medipol Acibadem District Hospital.

• Holds European Society for Medical Oncology (ESMO) board certification
• Completed clinical observerships at Cleveland Clinic and Harvard Medical School
• Specialises in treating lung adenocarcinomas and malignant melanomas
• Former specialist at Şişli Etfal Training and Research Hospital
• Focuses on targeted immunotherapy protocols for solid tumours

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Professor Raj Nagarkar has performed over 50,000 cancer surgeries and leads clinical research as the Chairperson of HCG Manavata Cancer Centre.

• Trained in surgical oncology at the prestigious Tata Memorial Hospital in Mumbai
• Completed advanced surgical training at the Royal College of Surgeons, Edinburgh
• Managed more than 200 clinical trials focusing on emerging cancer therapies
• Specialises in thoracic oncology with a focus on lung and breast cancers
• Serves as a Professor for the Delhi National Board of Examinations

Dr Shaunak Valame focuses on the molecular basis of cancer and specialises in targeted therapies at HCG Manavata Cancer Centre.

• Presented research on gastrointestinal cancer at the American Society of Clinical Oncology symposium in San Francisco
• Completed specialist medical oncology training at the prestigious Indraprastha Apollo Hospital in New Delhi
• Served as a senior resident and registrar in dedicated cancer research and treatment centres
• Experienced in administering the latest targeted therapies and immunotherapy protocols
• Regularly lectures for international oncology programmes on emerging cancer treatments